Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Guelph

$17,500.00

Investigating the role of Beclin-1 protein in the development of chronic pain

FY 2023-24

Summary
One in four Canadians over the age of 15 suffer from chronic pain; a rate that jumps to one in three in people over the age of 15. Current treatment options are inadequate, with less than half of all people undergoing treatment reporting any relieve of their pain. Investigating chronic pain through the lens of immune response could help us gain insight into body’s natural defense that begins upon an injury and through understanding such response, we can develop new effective treatments that will prevent pain from becoming chronic. It is common for practitioners to prescribe non-inflammatory medications to treat symptoms of pain, but such medications work by reducing inflammation in the body, ultimately disturbing the innate immune response. Recent work has challenged the use of NSAIDs for the treatment of pain as it is working against the body’s natural response towards getting back to normal state of recovery. The proposed research will determine if suppressing inflammation can prevent the development of chronic pain in a mouse model of chronic neuropathic pain. The proposed studies will use transgenic mice displaying a mutation of BECLIN-1, a key protein involved in inflammation. I will test the hypothesis that with reduction in the BECLIN-1 protein, there will be enhanced neuropathic pain observed in the mice models and such hypothesis will be tested with collection of behavioural tests and verification via molecular testing to analyze the biomarkers of chronic pain at different time points.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506576
Name
Zaheer Fariya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of Beclin-1 protein in the development of chronic pain
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Allodynia; Autophagy; Beclin-1 Protein; Chronic Pain; Chronification; Hyperalgesia; Inflammation; Nociception; Nsaids; Sex Differences
Abstract
One in four Canadians over the age of 15 suffer from chronic pain; a rate that jumps to one in three in people over the age of 15. Current treatment options are inadequate, with less than half of all people undergoing treatment reporting any relieve of their pain. Investigating chronic pain through the lens of immune response could help us gain insight into body’s natural defense that begins upon an injury and through understanding such response, we can develop new effective treatments that will prevent pain from becoming chronic. It is common for practitioners to prescribe non-inflammatory medications to treat symptoms of pain, but such medications work by reducing inflammation in the body, ultimately disturbing the innate immune response. Recent work has challenged the use of NSAIDs for the treatment of pain as it is working against the body’s natural response towards getting back to normal state of recovery. The proposed research will determine if suppressing inflammation can prevent the development of chronic pain in a mouse model of chronic neuropathic pain. The proposed studies will use transgenic mice displaying a mutation of BECLIN-1, a key protein involved in inflammation. I will test the hypothesis that with reduction in the BECLIN-1 protein, there will be enhanced neuropathic pain observed in the mice models and such hypothesis will be tested with collection of behavioural tests and verification via molecular testing to analyze the biomarkers of chronic pain at different time points.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zaheer, Fariya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~